Search

Carmine Cuda

Examiner (ID: 8210)

Most Active Art Unit
3205
Art Unit(s)
3201, 3205, 2878
Total Applications
602
Issued Applications
542
Pending Applications
0
Abandoned Applications
60

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5712158 [patent_doc_number] => 20060053504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Tissue specific expression of exogenous proteins in transgenic chickens' [patent_app_type] => utility [patent_app_number] => 10/524089 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 14646 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20060053504.pdf [firstpage_image] =>[orig_patent_app_number] => 10524089 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/524089
Tissue specific expression of exogenous proteins in transgenic chickens Aug 10, 2003 Abandoned
Array ( [id] => 7183818 [patent_doc_number] => 20040203152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Methods and compositions for genomic modification' [patent_app_type] => new [patent_app_number] => 10/636290 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23773 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203152.pdf [firstpage_image] =>[orig_patent_app_number] => 10636290 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636290
Methods and compositions for genomic modification Aug 4, 2003 Issued
Array ( [id] => 7343433 [patent_doc_number] => 20040191800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Uncoupling protein homologue: UCP3' [patent_app_type] => new [patent_app_number] => 10/627768 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5022 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191800.pdf [firstpage_image] =>[orig_patent_app_number] => 10627768 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/627768
Uncoupling protein homologue: UCP3 Jul 24, 2003 Abandoned
Array ( [id] => 7281545 [patent_doc_number] => 20040063922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Methods and compositions for catalytic DNA exchange in a sequence specific manner' [patent_app_type] => new [patent_app_number] => 10/391415 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32827 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063922.pdf [firstpage_image] =>[orig_patent_app_number] => 10391415 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/391415
Methods and compositions for catalytic DNA exchange in a sequence specific manner Jul 20, 2003 Abandoned
Array ( [id] => 7178440 [patent_doc_number] => 20050124037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells' [patent_app_type] => utility [patent_app_number] => 10/617835 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7994 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124037.pdf [firstpage_image] =>[orig_patent_app_number] => 10617835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/617835
Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells Jul 13, 2003 Abandoned
Array ( [id] => 7127266 [patent_doc_number] => 20050059010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Macular degeneration diagnostics and therapeutics' [patent_app_type] => utility [patent_app_number] => 10/619761 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30718 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059010.pdf [firstpage_image] =>[orig_patent_app_number] => 10619761 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/619761
Macular degeneration diagnostics and therapeutics Jul 13, 2003 Abandoned
Array ( [id] => 7216658 [patent_doc_number] => 20040088746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Apoptosis-inducing dna sequences' [patent_app_type] => new [patent_app_number] => 10/332859 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20515 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20040088746.pdf [firstpage_image] =>[orig_patent_app_number] => 10332859 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332859
Apoptosis-inducing dna sequences Jun 24, 2003 Abandoned
Array ( [id] => 698504 [patent_doc_number] => 07067281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Mammalian IAP gene family, primers, probes and detection methods' [patent_app_type] => utility [patent_app_number] => 10/600272 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 75 [patent_no_of_words] => 17369 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067281.pdf [firstpage_image] =>[orig_patent_app_number] => 10600272 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/600272
Mammalian IAP gene family, primers, probes and detection methods Jun 19, 2003 Issued
Array ( [id] => 6958575 [patent_doc_number] => 20050214945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Htlv-I tax induced killing of p53 null cancer cells' [patent_app_type] => utility [patent_app_number] => 10/514475 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10262 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214945.pdf [firstpage_image] =>[orig_patent_app_number] => 10514475 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514475
Htlv-I tax induced killing of p53 null cancer cells May 15, 2003 Abandoned
Array ( [id] => 662481 [patent_doc_number] => 07101689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Interleukin-18 binding proteins, their preparation and use' [patent_app_type] => utility [patent_app_number] => 10/434583 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 17952 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101689.pdf [firstpage_image] =>[orig_patent_app_number] => 10434583 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/434583
Interleukin-18 binding proteins, their preparation and use May 7, 2003 Issued
Array ( [id] => 1014500 [patent_doc_number] => 06893842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'T-type calcium channel variants; compositions thereof; and uses' [patent_app_type] => utility [patent_app_number] => 10/425800 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15603 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/893/06893842.pdf [firstpage_image] =>[orig_patent_app_number] => 10425800 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/425800
T-type calcium channel variants; compositions thereof; and uses Apr 28, 2003 Issued
Array ( [id] => 6769483 [patent_doc_number] => 20030215423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Gene therapy for obesity' [patent_app_type] => new [patent_app_number] => 10/419549 [patent_app_country] => US [patent_app_date] => 2003-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 11467 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215423.pdf [firstpage_image] =>[orig_patent_app_number] => 10419549 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/419549
Gene therapy for obesity Apr 20, 2003 Abandoned
Array ( [id] => 7219348 [patent_doc_number] => 20050260579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'TGF-beta type receptor cDNAs encoded products' [patent_app_type] => utility [patent_app_number] => 10/420192 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9655 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260579.pdf [firstpage_image] =>[orig_patent_app_number] => 10420192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/420192
TGF-beta type receptor cDNAs encoded products Apr 17, 2003 Abandoned
Array ( [id] => 6823042 [patent_doc_number] => 20030221203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'High efficiency regulatable gene expression system' [patent_app_type] => new [patent_app_number] => 10/148521 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12198 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20030221203.pdf [firstpage_image] =>[orig_patent_app_number] => 10148521 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/148521
High efficiency regulatable gene expression system Apr 3, 2003 Abandoned
Array ( [id] => 6664160 [patent_doc_number] => 20030203486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Transfection method and uses related thereto' [patent_app_type] => new [patent_app_number] => 10/403720 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23738 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203486.pdf [firstpage_image] =>[orig_patent_app_number] => 10403720 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/403720
Transfection method and uses related thereto Mar 27, 2003 Abandoned
Array ( [id] => 6678460 [patent_doc_number] => 20030228601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Transfection method and uses related thereto' [patent_app_type] => new [patent_app_number] => 10/403630 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23724 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228601.pdf [firstpage_image] =>[orig_patent_app_number] => 10403630 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/403630
Transfection method and uses related thereto Mar 27, 2003 Abandoned
Array ( [id] => 7133463 [patent_doc_number] => 20040043010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Delivery of bioactive compounds to an organism' [patent_app_type] => new [patent_app_number] => 10/393143 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 36209 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043010.pdf [firstpage_image] =>[orig_patent_app_number] => 10393143 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/393143
Delivery of bioactive compounds to an organism Mar 19, 2003 Abandoned
Array ( [id] => 7216581 [patent_doc_number] => 20050260178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Delivery of an organized tissue to an organism' [patent_app_type] => utility [patent_app_number] => 10/392500 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9378 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260178.pdf [firstpage_image] =>[orig_patent_app_number] => 10392500 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/392500
Delivery of an organized tissue to an organism Mar 19, 2003 Abandoned
Array ( [id] => 6806275 [patent_doc_number] => 20030233669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses' [patent_app_type] => new [patent_app_number] => 10/384172 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25556 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20030233669.pdf [firstpage_image] =>[orig_patent_app_number] => 10384172 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/384172
Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses Mar 4, 2003 Abandoned
Array ( [id] => 6866541 [patent_doc_number] => 20030192067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Delivery system' [patent_app_type] => new [patent_app_number] => 10/375050 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8838 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20030192067.pdf [firstpage_image] =>[orig_patent_app_number] => 10375050 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/375050
Delivery system Feb 27, 2003 Abandoned
Menu